Clients
The organizations building the diagnostic economy.
A selection of the diagnostics, therapeutics, wellness, and federal contracting organizations DMC is engaged with. Each description reflects the scope of work DMC performs.
Selected engagements
Current engagements across the value chain.
Lipidomics & precision diagnostics
Liponexus
Lipidomic diagnostics platform focused on cardiometabolic and neurodegenerative risk assessment. DMC's engagement covers commercialization and reimbursement strategy support.
Exosome diagnostics & therapeutics
ExoMD
Exosome-based diagnostics and regenerative medicine company. DMC's engagement covers commercialization pathway support, with regulatory and scientific specialists coordinated where required.
US federal & defense contracting
Kevin Peck — Federal & Defense Contracting
Advisory relationship focused on diagnostic and health-related opportunities with US federal agencies.
Peptides, GLP-1 & wellness clinics
BHN Healthcare Partners LLC
Wellness centers and clinics delivering peptide therapies, GLP-1 protocols, and adjunct wellness services. DMC provides operational and commercial guidance within an agreed scope. Led by Cleon Brown.
Additional client engagements are held in confidence and available upon request under NDA.
Begin the conversation
